COc1cccc(CC(NC(C)=O)C(=O)NC2CCN(c3ncccc3[N+](=O)[O-])CC2)c1
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?